Astellas Pharma Inc - Common Stock - Foreign

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / Common Stock - Foreign
Shares, excl. options Q2 2024
850K
Holdings value Q2 2024
$8.4M
Value change Q2 2024
+$3.31M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
2
Number of buys Q2 2024
1
Number of sells Q2 2024
0
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 850K $8.4M +$3.31M $9.88 2
2024 Q1 515K $5.53M +$125K $10.80 2
2023 Q4 503K $6.02M +$5.95M $11.96 2
2023 Q3 5.1K $70.9K -$225K $13.90 1
2023 Q2 20.2K $301K -$42.7K $14.88 2
2023 Q1 23.1K $327K -$1.08M $14.17 2
2022 Q4 99.7K $1.52M -$1.64M $15.25 2
2022 Q3 227K $3.01M $0 $13.24 2
2022 Q2 227K $3.54M +$187K $15.57 2
2022 Q1 215K $3.39M $0 $15.74 2
2021 Q4 215K $3.5M +$144K $16.24 2
2021 Q3 207K $3.41M -$263K $16.51 2
2021 Q2 222K $3.88M $0 $17.43 2
2021 Q1 222K $3.43M +$924K $15.40 2
2020 Q4 162K $2.51M $0 $15.44 1
2020 Q3 162K $2.41M +$775K $14.85 1
2020 Q2 110K $1.84M +$266K $16.68 1
2020 Q1 101K $1.57M -$121K $15.54 1
2019 Q4 109K $1.88M -$139K $17.22 1
2019 Q3 117K $1.67M +$4.27K $14.23 1
2019 Q2 117K $1.66M -$4.76M $14.23 1
2019 Q1 451K $6.75M +$160K $14.96 1
2018 Q4 441K $5.62M -$6.38K $12.75 1
2018 Q3 441K $7.69M -$368K $17.43 1
2018 Q2 462K $7.05M +$339K $15.25 1
2018 Q1 440K $6.69M -$1.09M $15.19 1
2017 Q4 512K $6.53M +$8.93K $12.76 1
2017 Q3 511K $6.5M +$6.5M $12.72 1
2016 Q4 0 $0 -$17M 0
2016 Q3 1.11M $17M -$29.5K $15.54 3
2016 Q2 1.11M $17.1M -$10.1M $15.60 3
2016 Q1 1.76M $23.2M +$1.82M $13.31 3
2015 Q4 1.62M $23.1M -$184M $14.39 3
2015 Q3 15.9M $205M -$207M $12.90 3
2015 Q2 16.1M $229M -$69.8M $14.26 3
2015 Q1 21M $344M +$223K $16.41 3
2014 Q4 21M $295M +$22.3M $14.07 3
2014 Q3 19.4M $288M +$47.6M $14.89 3
2014 Q2 16.2M $213M +$13.3M $13.14 3
2014 Q1 15.2M $180M +$151M $11.89 1